MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Bioventus ROA Ratio 2011-2026 | BVS
Annual ROA Ratio Bioventus
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19.27 | -11.56 | 1.58 | 3.32 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.32 | -19.27 | -6.48 |
Quarterly ROA Ratio Bioventus
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.45 | -3.24 | -4.91 | -5.43 | -5.2 | -17.64 | -24.76 | -31.61 | -31.77 | -9.28 | -9.45 | -1.87 | -1.91 | 3.24 | 4.95 | 6.82 | 6.29 | 2.76 | 2.76 | 1.05 | 2.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.82 | -31.77 | -5.55 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M |  USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 23.08 | 1.7 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 29.14 | -3.75 % | $ 326 M |  China |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.1 | 0.46 % | $ 1.4 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
-37.07 | - | - | $ 79.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 11.38 | 1.16 % | $ 323 M | Israel |
 |
DexCom
DXCM
|
13.19 | $ 70.29 | 8.0 % | $ 27.4 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 103.65 | -1.16 % | $ 4.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 32.89 | 3.09 % | $ 914 M | USA |
 |
Danaher Corporation
DHR
|
5.03 | $ 211.14 | -1.74 % | $ 154 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 205.13 | -0.82 % | $ 22.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 23.24 | 1.18 % | $ 703 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 19.6 | 2.62 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.85 | - | $ 8.12 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 103.32 | 0.09 % | $ 19.1 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 68.71 | -0.02 % | $ 4.75 B | USA |
 |
Guardant Health
GH
|
-29.37 | $ 104.76 | 1.95 % | $ 12.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
National Research Corporation
NRC
|
25.3 | $ 12.09 | -5.81 % | $ 297 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
0.29 | $ 160.2 | 0.91 % | $ 8.23 B | USA |
 |
IDEXX Laboratories
IDXX
|
26.96 | $ 627.58 | 1.68 % | $ 51.8 B | USA |
 |
Illumina
ILMN
|
-19.4 | $ 115.9 | 1.27 % | $ 18.4 B | USA |
 |
OPKO Health
OPK
|
0.64 | $ 1.24 | 2.48 % | $ 861 M | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 166.72 | -1.27 % | $ 30.2 B | USA |
 |
Natera
NTRA
|
-39.28 | $ 204.66 | -1.53 % | $ 20.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 31.11 | -0.94 % | $ 20 B | Niderland |
|
Biodesix
BDSX
|
-44.15 | $ 11.55 | 6.6 % | $ 1.5 B | USA |
 |
Personalis
PSNL
|
-30.08 | $ 8.22 | -2.09 % | $ 487 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 281.39 | 1.13 % | $ 23.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 95.34 | 19.06 % | $ 7.86 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
43.3 | $ 23.61 | -0.55 % | $ 995 M | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.25 | 4.19 % | $ 5.17 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 429.09 | 3.14 % | $ 12.4 B | USA |